Back
4D Molecular Therapeutics, Inc. (FDMT)
BiotechnologyFDMT · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$12.91
+1.49%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$-2.42
ROE
-34.9%
Gross margin
-145.7%
Debt/Equity
4.54x
Revenue growth
21664.3%
4D Molecular Therapeutics, Inc. — company intelligence
Earnings surprises
Q1 2026$-1.01 vs $-1.01 est+0.2%
Q4 2025$0.43 vs $-0.78 est+155.3%
Q3 2025$-1.01 vs $-1.00 est-1.2%
Q2 2025$-0.98 vs $-0.89 est-9.7%
Analyst consensus · 17 analysts
14 Buy3 Hold0 Sell
Updated Jul 5, 2026
Insider activity · 90 days
7 buys2 sellsnet +258,332 shares
Bizily Scottother 9,810 · Jun 23, 2026
Kirn DavidSell 114,746 · Jun 22, 2026
GRAY SUSANNAHBuy 50,000 · Jun 17, 2026
Recent SEC filings
4 — Insider transaction reportJul 2, 2026
8-K — Material event reportJun 29, 2026
4 — Insider transaction reportJun 25, 2026
Latest news
4D Molecular Therapeutics Completes Enrollment For Its 4FRONT-2 Second Phase 3 Clinical Trial Evaluating 4D-150 In Patients With Wet Age-Related Macular Degeneration — Benzinga · 1w ago
4D Molecular Therapeutics, Inc. (FDMT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript — SeekingAlpha · Jun 10, 2026
4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies Global Healthcare Conference 2026 Transcript — SeekingAlpha · Jun 5, 2026
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About 4D Molecular Therapeutics, Inc.
Weekly undervalued picks (like FDMT)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.